User menu

Randomized phase 3 study of panitumumab with FOLFOX4 compared to FOLFOX4 alone as 1(st)-line treatment (tx) for metastatic colorectal cancer (mCRC): the PRIME trial

Bibliographic reference Douillard, Jean-Yves ; Siena, Salvatore ; Cassidy, James ; Tabernero, Josef ; Burkes, Ronald ; et. al. Randomized phase 3 study of panitumumab with FOLFOX4 compared to FOLFOX4 alone as 1(st)-line treatment (tx) for metastatic colorectal cancer (mCRC): the PRIME trial.15th ECCO/34th ESMO Multidisciplinary Congress ((Germany) Berlin, du 20/09/2009 au 24/09/2009). In: EJC - Supplements, Vol. 7, no. 3, p. 6 (2009)
Permanent URL http://hdl.handle.net/2078.1/58855